Form 4: Verizon Executive Kyle Malady Reports Acquisition of Phantom Stock
SEC Form 4 Filing
EVP and Group CEO of Verizon Business, Kyle Malady, reports acquiring phantom stock units equivalent to 150.538 shares of common stock through a deferred compensation plan.
Summary
- Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., filed a Form 4 on November 12, 2024, reporting a transaction on November 7, 2024.
- The transaction involved the acquisition of 150.538 units of phantom stock at a price of $11.57 each, through a deferred compensation plan.
- Following the reported transaction, Malady beneficially owns 359,426.866 units of phantom stock, including those acquired through dividend reinvestment.
- The phantom stock is the economic equivalent of Verizon common stock and is settled in cash upon events established by the reporting person in accordance with the deferred compensation plan.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to executive compensation. It doesn't inherently convey positive or negative sentiment.
Positives
- The acquisition of phantom stock through a deferred compensation plan can be seen as a positive sign of executive alignment with the company's long-term performance.
Industry Context
Executive compensation packages often include phantom stock to align executive interests with shareholder value. This filing is a routine disclosure of such a transaction.
Comparison to Industry Standards
- Phantom stock grants are a common component of executive compensation packages in publicly traded companies, particularly in large corporations like Verizon.
- Companies like AT&T and T-Mobile also utilize similar compensation strategies to incentivize their executives.
Stakeholder Impact
- The acquisition of phantom stock by an executive can have a minor positive impact on shareholders by aligning management's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 11/07/2024 | Date of transaction: Acquisition of phantom stock. |
| 11/12/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.